Analysed VISTAGEN THERAPEUTICS INC (VTGN:NASDAQ) News Sources
Vistagen Therapeutics Inc (VTGN) Q3 2026 Earnings Call Highlights: Progress in Clinical Trials ...
13-02-2026
yahoo.com
Vistagen Reports Fiscal Year 2026 Third Quarter Financial Results and Provides Corporate Update
12-02-2026
yahoo.com
Vistagen to Report Fiscal Year 2026 Third Quarter Results and Host Corporate Update Conference Call on February 12, 2026
04-02-2026
yahoo.com
Vistagen Announces Topline Results from PALISADE-3 Phase 3 Public Speaking Challenge Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder
17-12-2025
yahoo.com
What is the current price of VISTAGEN THERAPEUTICS INC (VTGN:NASDAQ)?
The current price of VISTAGEN THERAPEUTICS INC (VTGN:NASDAQ) is $0.5604.
VISTAGEN THERAPEUTICS INC (VTGN:NASDAQ) absolute price change since previous trading day?
The absolute price change of VISTAGEN THERAPEUTICS INC (VTGN:NASDAQ) since the previous trading day is $0.0045.
VISTAGEN THERAPEUTICS INC (VTGN:NASDAQ) percentage price change since previous trading day?
The percentage price change of VISTAGEN THERAPEUTICS INC (VTGN:NASDAQ) since the previous trading day is 0.8095%.
What is the most recent average sentiment score for VISTAGEN THERAPEUTICS INC (VTGN:NASDAQ)?
The most recent average sentiment score for VISTAGEN THERAPEUTICS INC (VTGN:NASDAQ) is 73 out of 100.
What is the most recent average sentiment for VISTAGEN THERAPEUTICS INC (VTGN:NASDAQ)?
The most recent sentiment for VISTAGEN THERAPEUTICS INC (VTGN:NASDAQ) is .
SEC-8K** Filing Available For VISTAGEN THERAPEUTICS INC (VTGN:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.